PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients.
暂无分享，去创建一个
R. Danesi | F. Cucchiara | M. Del Re | S. Crucitta | A. Fontana | C. De Angelis | L. Diodati | B. Salvadori | M. Roncella | M. Ghilli | G. Lorenzini | D. Cavallero | I. Bargagna | P. Cinacchi | B. Fratini | Diletta Cavallero